[go: up one dir, main page]

Influenza A Virus, H1N1 Subtype

"Influenza A Virus, H1N1 Subtype" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

expand / collapse MeSH information
A subtype of INFLUENZA A VIRUS with the surface proteins hemagglutinin 1 and neuraminidase 1. The H1N1 subtype was responsible for the Spanish flu pandemic of 1918.


expand / collapse Publications
This graph shows the total number of publications written about "Influenza A Virus, H1N1 Subtype" by people in this website by year, and whether "Influenza A Virus, H1N1 Subtype" was a major or minor topic of these publications.
Below are the most recent publications written about "Influenza A Virus, H1N1 Subtype" by people in Profiles.
  1. Portable UV-C device to treat high flow of infectious aerosols generated during clinical respiratory care. Sci Rep. 2024 Dec 30; 14(1):31799.
    View in: PubMed
  2. Targets of influenza human T-cell response are mostly conserved in H5N1. mBio. 2025 Feb 05; 16(2):e0347924.
    View in: PubMed
  3. Coupling antigens from multiple subtypes of influenza can broaden antibody and T cell responses. Science. 2024 Dec 20; 386(6728):1389-1395.
    View in: PubMed
  4. Outcome of SARS-CoV-2 reinfection depends on genetic background in female mice. Nat Commun. 2024 Nov 23; 15(1):10178.
    View in: PubMed
  5. Epidemiology and population-based incidence of influenza in two communities, Bandung district, West Java, Indonesia, 2008-2011. Narra J. 2024 Dec; 4(3):e981.
    View in: PubMed
  6. Antiviral Susceptibility of Swine-Origin Influenza A Viruses Isolated from Humans, United States. Emerg Infect Dis. 2024 Nov; 30(11):2303-2312.
    View in: PubMed
  7. Immunophenotypic predictors of influenza vaccine immunogenicity in pediatric hematopoietic cell transplant recipients. Blood Adv. 2024 04 23; 8(8):1880-1892.
    View in: PubMed
  8. Vaccine Effectiveness Against Influenza A-Associated Hospitalization, Organ Failure, and Death: United States, 2022-2023. Clin Infect Dis. 2024 Apr 10; 78(4):1056-1064.
    View in: PubMed
  9. Hydroxypropyl-Beta Cyclodextrin Barrier Prevents Respiratory Viral Infections: A Preclinical Study. Int J Mol Sci. 2024 Feb 08; 25(4).
    View in: PubMed
  10. Maternal Vaccine Effectiveness Against Influenza-Associated Hospitalizations and Emergency Department Visits in Infants. JAMA Pediatr. 2024 Feb 01; 178(2):176-184.
    View in: PubMed